Clinical trial
Feasibility of Emergency Department Initiated Extended-Release Naltrexone and Case Management Services for the Treatment of Alcohol Use Disorder
NCT04094584 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Emergency Department Initiated Extended-Release Naltrexone and Case Management Services for the Treatment of Alcohol Use Disorder
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- August 14, 2020
- Completion date
- May 1, 2022
- Enrollment
- 179 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol abuse or dependence, alcohol use disorder, substance use